A novel tumor marker, Niban, is expressed in subsets of thyroid tumors and Hashimoto's thyroiditis

Human Pathology

Volumn 37, Issue 12, 2006, Pages 1592-1600

  Matsumoto, Fumihiko ^a   Fujii, Hiroaki ^a   Abe, Masaaki ^a   Kajino, Kazunori ^a   Kobayashi, Toshiyuki ^a   Matsumoto, Toshiharu ^a   Ikeda, Katsuhisa ^a   Hino, Okio ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hashimoto's thyroiditis; H rthle cell; Niban; Oxyphilic tumor; Papillary thyroid carcinoma; Thyroid

Indexed keywords

POLYCLONAL ANTIBODY; PROTEIN; PROTEIN NIBAN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOMA; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METAPLASIA; MITOCHONDRION; PAPILLARY CARCINOMA; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; THYROID GLAND; THYROID TUMOR; UPREGULATION; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, PAPILLARY; HASHIMOTO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 33751256302     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.06.022     Document Type: Article

References (15)

1. Adachi H., Majima S., Kon S., et al. Niban gene is commonly expressed in the renal tumors: a new candidate marker for renal carcinogenesis. Oncogene 23 (2004) 3495-3500
2. Hino O. Hereditary renal carcinogenesis fitting Knudson's two-hit model: genotype, environment, and phenotype. Genes Chromosomes Cancer 38 (2003) 357-367
3. Hino O., Kobayashi T., Momose S., Kikuchi Y., Adachi H., and Okimoto K. Renal carcinogenesis: genotype, phenotype and dramatype. Cancer Sci 94 (2003) 142-147
4. Majima S., Kajino K., Fukuda T., Otsuka F., and Hino O. A novel gene "Niban" upregulated in renal carcinogenesis: cloning by the cDNA-amplified fragment length polymorphism approach. Jpn J Cancer Res 91 (2000) 869-874
5. Berho M., and Suster S. The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. Hum Pathol 28 (1997) 47-53
6. Joseph A.M., Rungi A.A., Robinson B.H., and Hood D.A. Compensatory responses of protein import and transcription factor expression in mitochondrial DNA defects. Am J Physiol Cell Physiol 286 (2004) 3
7. Maximo V., and Sobrinho-Simoes M. Hurthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch 437 (2000) 107-115
8. Sobrinho-Simoes M., Maximo V., Castro I.V., et al. Hurthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Int J Surg Pathol 13 (2005) 29-35
9. Asa S.L. My approach to oncocytic tumours of the thyroid. J Clin Pathol 57 (2004) 225-232
10. Arif S., Blanes A., and Diaz-Cano S.J. Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma. Histopathology 41 (2002) 357-362
11. Crile Jr. G. Struma lymphomatosa and carcinoma of the thyroid. Surg Gynecol Obstet 147 (1978) 350-352
12. Holm L.E., Blomgren H., and Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 312 (1985) 601-604
13. Ott R.A., McCall A.R., McHenry C., et al. The incidence of thyroid carcinoma in Hashimoto's thyroiditis. Am Surg 53 (1987) 442-445
14. Muller-Hocker J., Jacob U., and Seibel P. Hashimoto thyroiditis is associated with defects of cytochrome-c oxidase in oxyphil Askanazy cells and with the common deletion (4,977) of mitochondrial DNA. Ultrastruct Pathol 22 (1998) 91-100
15. Cerutti J.M., Delcelo R., Amadei M.J., et al. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 113 (2004) 1234-1242